In multiple myeloma, the t(4;14)(p16.3;q32) translocation leads to deregulation of FGFR3 and WHSC1/MMSET and is found in up to 20% of newly diagnosed patients (9). This evidence concerns the gene NSD2 and plasma cell myeloma.